Array
(
[1553171413] => Array
(
[wordfence_processAttackData] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1553171973] => Array
(
[wp_privacy_delete_old_export_files] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1553172481] => Array
(
[wpm_update_stats] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1553173952] => Array
(
[wordfence_hourly_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1553175126] => Array
(
[wp_update_themes] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_version_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_update_plugins] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1553175874] => Array
(
[wp_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553181473] => Array
(
[wp_session_garbage_collection] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1553184424] => Array
(
[akismet_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553187411] => Array
(
[yoast_tracking] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553244571] => Array
(
[wp_scheduled_auto_draft_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553249711] => Array
(
[delete_expired_transients] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553249752] => Array
(
[wpseo-reindex-links] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553256752] => Array
(
[wordfence_daily_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1553526000] => Array
(
[wordfence_email_activity_report] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1553554832] => Array
(
[publish_future_post] => Array
(
[aa11aa901e9c7fa426bc76aa2905e5a4] => Array
(
[schedule] =>
[args] => Array
(
[0] => 427034
)
)
)
)
[1553641250] => Array
(
[publish_future_post] => Array
(
[1f3d24059f96d9e259518bca8d2c4d45] => Array
(
[schedule] =>
[args] => Array
(
[0] => 399265
)
)
)
)
[1553641252] => Array
(
[publish_future_post] => Array
(
[f424dbe879bbeb64820a496b9b964c34] => Array
(
[schedule] =>
[args] => Array
(
[0] => 425172
)
)
)
)
[1554069658] => Array
(
[publish_future_post] => Array
(
[30870f619857112e7f5a94a898b1f874] => Array
(
[schedule] =>
[args] => Array
(
[0] => 428209
)
)
)
)
[1554674448] => Array
(
[publish_future_post] => Array
(
[ff60c73b1e4862a319c959dd8a390668] => Array
(
[schedule] =>
[args] => Array
(
[0] => 426546
)
)
)
)
[1560808829] => Array
(
[publish_future_post] => Array
(
[b5d3dc26a5d6e8c9ef68ff7210d9c108] => Array
(
[schedule] =>
[args] => Array
(
[0] => 413991
)
)
)
)
[1572217239] => Array
(
[publish_future_post] => Array
(
[e2d49b23925e3371aea8db1c72521461] => Array
(
[schedule] =>
[args] => Array
(
[0] => 421241
)
)
)
)
[1580169600] => Array
(
[publish_future_post] => Array
(
[2d492587fa52e9c78f7043ddf937b0a1] => Array
(
[schedule] =>
[args] => Array
(
[0] => 18611
)
)
[dea3edad73162f380bc9dc44fa3407bf] => Array
(
[schedule] =>
[args] => Array
(
[0] => 19670
)
)
[2caa9c58a241c4f77a6856802c1b43fb] => Array
(
[schedule] =>
[args] => Array
(
[0] => 20734
)
)
[307b37ba29b8cd716eafa809661756e3] => Array
(
[schedule] =>
[args] => Array
(
[0] => 22852
)
)
[365be9eba8e62abb0c0d4bfe013a2687] => Array
(
[schedule] =>
[args] => Array
(
[0] => 23918
)
)
[0e942b20ffb9550322105263ad82126f] => Array
(
[schedule] =>
[args] => Array
(
[0] => 24977
)
)
[661c5eb39689fe2133ff7986ac6628fb] => Array
(
[schedule] =>
[args] => Array
(
[0] => 26036
)
)
[75562b264e355915e4dea97042a28f7e] => Array
(
[schedule] =>
[args] => Array
(
[0] => 27095
)
)
[11cf4e8a6f842b0115881551a29c47f6] => Array
(
[schedule] =>
[args] => Array
(
[0] => 28154
)
)
[55a38aaca11da398c854cb29a7d4f5e6] => Array
(
[schedule] =>
[args] => Array
(
[0] => 30272
)
)
[f8cbc904676c235c7057ec965c01c023] => Array
(
[schedule] =>
[args] => Array
(
[0] => 32390
)
)
)
)
)
Documento de criterios y estándares para la designación de centros para utilizacion de CAR-T en linfoma difuso de células B grandes recidivante o refractario y en leucemia linfoblástica aguda de células B refractaria en el Sistema Nacional de Salud, publicado por el Ministerio de Sanidad.
Etiquetas: 5 de marzo de 2019, CAR-T, Centros, Criterios, Designación, Leucemia, linfoma, Madrid, Ministerio de Sanidad, salud, Sanidad, Terapias.
Etiquetas: 29 de mayo de 2008, Alteraciones congénitas del desarrollo ocular, Área de trasplantes, Área de Traumatología y Ortopedia, Centros, Comité, CSUR, Designación, España, Justificación de las propuestas y criterios para la designación de los CSUR, Osteotomía Pélvica en discipilas de cadera en el adulto, Primera propuesta de centros para ser designados como referencia del Sistema Nacional de Salud, Retinopatía del prematuro avanzada, Servicios, Sistema Nacional de Salud, TPH, Trasplante hepático de vivo adulto, Tratamiento de tumores germinales con quimioterapia intensiva, Tumores intraoculares del adulto, Tumores musculoesqueléteicos, Unidades de referencia.
Utilizamos cookies propias y de terceros para recopilar información que ayuda a optimizar su visita. Las cookies no se utilizan para recoger información de carácter personal. Usted puede permitir su uso o rechazarlo, también puede cambiar su configuración siempre que lo desee. Al continuar con la navegación entendemos que se acepta nuestra política de cookies.
x.gif)